🇺🇸 FDA
Patent

US 10322095

Endoxifen for local transdermal therapy to the breast

granted A61KA61K31/138A61K47/10

Quick answer

US patent 10322095 (Endoxifen for local transdermal therapy to the breast) held by Northwestern University expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/138, A61K47/10, A61K47/12, A61K9/0014